The data from our recent study using a bleomycin-induced fibrotic lung injury mouse model demonstrate that the homologous protein of bombesin receptor–activated protein (BRAP) might be a negative regulator of pulmonary fibrosis. The gene discussed is BRAP; the disease is pulmonary fibrosis.